Antiviral Forms and Information

Clinician Guidance

• Pediatric Guidance for Providing Tamiflu Capsules to Pediatric Patients 1 – 12 Years Old (8/27/09) (pdf, 54 kb)
  • Instruction sheets for preparing dosages (10/26/09)
    • Prophylaxis – 30 mg (pdf, 23 kb) – En español (pdf, 21 kb)
    • Prophylaxis – 45 mg (pdf, 23 kb) – En español (pdf, 23 kb)
    • Prophylaxis – 60 mg (pdf, 21 kb) – En español (pdf, 21 kb)
    • Prophylaxis – 75 mg (pdf, 21 kb) – En español (pdf, 21 kb)
    • Treatment – 30 mg (pdf, 23 kb) – En español (pdf, 21 kb)
    • Treatment – 45 mg (pdf, 21 kb) – En español (pdf, 21 kb)
    • Treatment – 60 mg (pdf, 21 kb) – En español (pdf, 22 kb)
    • Treatment – 75 mg (pdf, 23 kb) – En español (pdf, 21 kb)

Antiviral Forms and Information

State Antiviral Pharmacy List - (11/12/09)

Peramivir FDA Emergency Use Authorization - (10/25/09)

Recommendations for Early Empiric Antiviral Treatment in Persons With Suspected Influenza Who are at Increased Risk of Developing Severe Disease - (10/19/09)

DOH Provider Agreement for Non-vaccine Medical Countermeasures Appendices A B C C (Supp1) D and E - (10/20/09)

DOH Provider Agreement for Non-vaccine Medical Countermeasures Appendices D and E - (10/20/09)

Emergency Authorization for Dispensing of Anti-virals from In-patient Hospital Pharmacies and Public Health Clinics - (10/15/09)

NMDOH Antiviral Transfer Reporting Form - (10/29/09)

NMDOH Antiviral Form - Sample - pdf - (11/04/09)

NMDOH Antiviral Form - pdf - (11/04/09)

Antiviral & Personal Protective Equipment Request Form (11/04/09)

FDA Tamiflu for Influenza A H1N1

FDA Relenza Letter for Emergency Use Authorization

FDA Relenza Healthcare Provider Fact Sheet

FDA Relenza Patient Fact Sheet

FDA Relenza Prescribing Information

FDA Tamiflu Healthcare Provider Fact Sheet

FDA Tamiflu Patient Provider Fact Sheet

FDA Tamiflu Prescribing Information

FDA Tamiflu and Infants

NMDOH Antiviral Shipments Hospitals

NMDOH Antiviral Shipments Clinics

FDA Tamiflu Letter for Emergency Use Authorization